SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-05-016429
Filing Date
2005-04-14
Accepted
2005-04-14 13:31:50
Documents
4
Period of Report
2005-05-18
Effectiveness Date
2005-04-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A a05-5902_1def14a.htm DEF 14A 386768
2 GRAPHIC g59021bcv1image002.gif GRAPHIC 610
3 GRAPHIC g59021bev1image002.gif GRAPHIC 610
4 GRAPHIC g59021div1image002.gif GRAPHIC 4748
  Complete submission text file 0001104659-05-016429.txt   397012
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14895 | Film No.: 05750268
SIC: 2834 Pharmaceutical Preparations